WHO ICTRP trial

FRONTIER-AP Vision: Randomized controlled trial of endovascular versus standard…

ACTRN12624000727549 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12624000727549
Public title FRONTIER-AP Vision: Randomized controlled trial of endovascular versus standard medical therapy for stroke with occlusion of posterior cerebral artery.
Scientific title FRONTIER-AP Vision: Randomized controlled trial of endovascular versus standard medical therapy for stroke with occlusion of posterior cerebral artery.
Primary sponsor National Health and Medical Research Council Clinical Trial and Cohort
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia;New Zealand
Conditions stroke; stroke;Stroke - Ischaemic
Interventions :Patients randomized to the thrombectomy arm will have clot extraction or aspiration catheter in the angiographic suite. This decision is up to the interventional radiologists performing the procedure. The procedure may take 1 hour but can…
Registration date Jun 13, 2024
Target size 230
Secondary IDs Nil known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations